Evidence map›Paper›PMID 41757911›Full record

ArticleMicrobiology spectrum2026

Genetic diversity and drug resistance profiles of

Yeshiwork Abebaw, Abaysew Ayele, Dawit Hailu Alemayehu, Gebremedhin Gebremicael, Getu Diriba, Atsbeha Gebreegziabxier Weldemariam, Betselot Zerihun, Shewki Moga, Bethlehem Adnew, Kalkidan Melaku and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yeshiwork AbebawDepartment of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0001-6039-3430
Abaysew AyeleArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Dawit Hailu AlemayehuArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Gebremedhin GebremicaelEthiopian Public Health Institute, Addis Ababa, Ethiopia.ORCID 0000-0001-6726-9600
Getu DiribaEthiopian Public Health Institute, Addis Ababa, Ethiopia.ORCID 0000-0002-0166-682X
Atsbeha Gebreegziabxier WeldemariamEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Betselot ZerihunEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Shewki MogaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Bethlehem AdnewArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Kalkidan MelakuArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Muluwork GetahunEthiopian Public Health Institute, Addis Ababa, Ethiopia.ORCID 0000-0003-3407-983X
Rahel ArgawDepartment of Pediatrics and Child Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Anandi ShethDepartment of Medicine, School of Medicine, Emory University, Atlanta, Georgia, USA.
Markos AbebeArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Woldaregay Erku AbegazDepartment of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
FIC NIH HHS D43 TW009127FIC NIH HHS D43TW009127
6 · The paper itself

Abstract

Ethiopia ranks 30th among the tuberculosis (TB) burden countries, with children representing a significant yet understudied population group. This study aims to investigate the genetic diversity and drug-resistant profile among Ethiopian children. We included children under 15 years of age diagnosed with culture-confirmed pulmonary TB/drug-resistant TB between January 2017 and June 2023. Phenotypic drug susceptibility testing and whole-genome sequencing were conducted for 85 IMPORTANCE: Our findings revealed a high genetic diversity of

Indexed as

Antitubercular AgentsDrug Resistance, Multiple, BacterialGenetic VariationMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentBacterial ProteinsCatalaseChildChild, PreschoolDNA-Directed RNA PolymerasesEthiopiaFemaleHumansInfantMaleAntitubercular AgentsBacterial ProteinsCatalaseDNA-Directed RNA PolymeraseschildrenEthiopiaphenotypic drug susceptibility testingregiontuberculosiswhole-genome sequencing

Identifiers

PMID41757911
PMCPMC13055266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.